Journey Medical Corporation Quarterly report pursuant to Section 13 or 15(d)

INTEREST EXPENSE

6 Months Ended

Jun. 30, 2022

NOTE 14. INTEREST EXPENSE

Interest expense consisted of the following:


	Three-month periods ended				Six-month periods ended
	June 30,				June 30,
	2022		2021		2022		2021
Interest payments on EWB term loan	$	216	$	—	$	377	$	—
Imputed Interest on acquired intangible assets		151		220		299		441
Amortization/Accretion		87		—		167		—
Fees on convertible preferred shares		—		270		—		270
Conversion premium ¹		—		584		—		584
Interest payable on convertible preferred shares		—		263		—		263
EWB Fees		—		5		—		5
Total Interest Expense	$	454	$	1,342	$	843	$	1,563

¹The conversion premium relates to the 15% discount at which the Class A Preferred Stock converted.